Published in J Transl Med on December 01, 2008
Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med (2014) 1.87
Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen (2014) 1.16
Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem (2012) 1.04
Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev (2015) 1.02
Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts. Epigenetics (2014) 0.81
Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds. Tissue Eng Part C Methods (2015) 0.81
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J Clin Invest (2016) 0.81
Nanotechnology-Driven Therapeutic Interventions in Wound Healing: Potential Uses and Applications. ACS Cent Sci (2017) 0.77
Biology and Biomarkers for Wound Healing. Plast Reconstr Surg (2016) 0.76
Low Intensity Pulsed Ultrasound (LIPUS) promotes cell motility through vinculin-controlled Rac1 GTPase activity. J Cell Sci (2017) 0.75
MicroRNA-132 promotes fibroblast migration via regulating RAS p21 protein activator 1 in skin wound healing. Sci Rep (2017) 0.75
Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14
Cellular and molecular basis of wound healing in diabetes. J Clin Invest (2007) 4.22
Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem (1995) 3.30
Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol (2004) 3.13
Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes (2007) 2.95
Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol (2005) 2.21
Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med (2007) 2.06
Risk factors for foot infections in individuals with diabetes. Diabetes Care (2006) 1.96
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen (1999) 1.60
Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res (2002) 1.52
Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol (1997) 1.50
COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A (2006) 1.42
Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol (2006) 1.30
Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen (1994) 1.28
Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia (2006) 1.28
Clinical approach to wounds: débridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg (2006) 1.20
Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg (2006) 1.16
Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb Haemost (2004) 1.15
Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg (1998) 1.15
Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol (2002) 1.14
Detection of anaerobic mycoplasmas in cell cultures. In Vitro (1973) 1.14
Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res (1999) 1.13
Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol (1999) 1.10
Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med (2008) 1.08
Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci (1997) 1.06
Fibroblast senescence in pressure ulcers. Wound Repair Regen (1999) 1.04
Denatured collagen modulates the phenotype of normal and wounded human skin equivalents. J Invest Dermatol (2008) 1.03
Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol (2000) 1.02
Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg (2006) 1.00
Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg (1997) 0.99
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother (2001) 0.95
Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci (1998) 0.92
Clonal characterization of fibroblasts in the superficial layer of the adult human dermis. Cell Tissue Res (2006) 0.87
Patterns of venous reflux and obstruction in patients with skin damage due to chronic venous disease. Vasc Endovascular Surg (2007) 0.82
Effects of prolonged compression on the variations of haemoglobin oxygenation - assessment by spectral analysis of reflectance spectrophotometry signals. Phys Med Biol (2006) 0.82
Validation of routine mycoplasma testing by PCR. In Vitro Cell Dev Biol Anim (1998) 0.81
Granulocyte macrophage colony stimulating factor (GM-CSF) biological actions on human dermal fibroblasts. Eur J Histochem (2001) 0.77
Venous ulcer fibroblasts respond to basic fibroblast growth factor at the cell cycle protein level. Ann Vasc Surg (2006) 0.76
Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14
Cellular and molecular basis of wound healing in diabetes. J Clin Invest (2007) 4.22
The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68
Impaired wound healing. Clin Dermatol (2007) 2.29
Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol (2005) 2.21
Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med (2007) 2.06
Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys (2002) 1.89
Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J Invest Dermatol (2009) 1.68
The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A (2007) 1.45
Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing. Biol Cell (2005) 1.43
Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem (2006) 1.43
Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem (2011) 1.36
Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One (2013) 1.32
Generating disulfides in multicellular organisms: emerging roles for a new flavoprotein family. J Biol Chem (2007) 1.29
Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen (2007) 1.23
Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Int (2003) 1.17
The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol Cell Biol (2004) 1.16
Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen (2014) 1.16
Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage. J Trauma (2007) 1.14
A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol (2008) 1.13
Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med (2008) 1.08
Transcriptional profiling of epidermal keratinocytes: comparison of genes expressed in skin, cultured keratinocytes, and reconstituted epidermis, using large DNA microarrays. J Invest Dermatol (2003) 1.08
The synergism of age and db/db genotype impairs wound healing. Exp Gerontol (2007) 1.07
ADAM12: a potential target for the treatment of chronic wounds. J Mol Med (Berl) (2008) 1.06
Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med (2010) 1.05
Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem (2012) 1.04
From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing. J Mol Biol (2004) 1.01
The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen (2010) 0.99
Role of keratinocytes in healing of chronic wounds. Surg Technol Int (2008) 0.99
Streptolysin O enhances keratinocyte migration and proliferation and promotes skin organ culture wound healing in vitro. Wound Repair Regen (2007) 0.98
Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen (2015) 0.97
Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers. Surg Technol Int (2003) 0.96
Using gene transcription patterns (bar coding scans) to guide wound debridement and healing. Adv Skin Wound Care (2008) 0.94
Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratinocytes. Exp Cell Res (2009) 0.94
Role of Scarf and its binding target proteins in epidermal calcium homeostasis. J Biol Chem (2007) 0.92
An in silico approach to the analysis of acute wound healing. Wound Repair Regen (2009) 0.91
Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Mol Endocrinol (2007) 0.91
Wound healing primer. Surg Clin North Am (2010) 0.90
Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. J Biol Chem (2009) 0.90
Systems approaches to the networks of aging. Ageing Res Rev (2006) 0.90
US-National Institutes of Health-funded research for cutaneous wounds in 2012. Wound Repair Regen (2013) 0.89
Keratin dressings speed epithelialization of deep partial-thickness wounds. Wound Repair Regen (2012) 0.89
Thyroid hormones and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol (2004) 0.88
Androstenetriol immunomodulation improves survival in a severe trauma hemorrhage shock model. J Trauma (2007) 0.86
Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int (2003) 0.86
The book of opposites: the role of the nuclear receptor co-regulators in the suppression of epidermal genes by retinoic acid and thyroid hormone receptors. J Invest Dermatol (2005) 0.85
Dual-specificity phosphatases in the hypo-osmotic stress response of keratin-defective epithelial cell lines. Exp Cell Res (2008) 0.84
The role of surgical debridement in healing of diabetic foot ulcers. Skinmed (2012) 0.83
Analysis and meta-analysis of transcriptional profiling in human epidermis. Methods Mol Biol (2014) 0.83
Comprehensive transcriptional profiling of human epidermis, reconstituted epidermal equivalents, and cultured keratinocytes using DNA microarray chips. Methods Mol Biol (2010) 0.82
Deep tissue injury in development of pressure ulcers: a decrease of inflammasome activation and changes in human skin morphology in response to aging and mechanical load. PLoS One (2013) 0.82
Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds. Tissue Eng Part C Methods (2015) 0.81
Surgical pathology to describe the clinical margin of debridement of chronic wounds using a wound electronic medical record. J Am Coll Surg (2009) 0.81
Developing and evaluating outcomes of an evidence-based protocol for the treatment of osteomyelitis in Stage IV pressure ulcers: a literature and wound electronic medical record database review. Ostomy Wound Manage (2009) 0.80
Human ex vivo wound healing model. Methods Mol Biol (2013) 0.80
Operative debridement of pressure ulcers. World J Surg (2009) 0.80
A coordinated approach to cutaneous wound healing: vibrational microscopy and molecular biology. J Cell Mol Med (2008) 0.80
Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome. Immunol Res (2013) 0.79
Androstenediol reverses steroid-inhibited wound healing. Wound Repair Regen (2009) 0.79
Chronic wound repair and healing in older adults: current status and future research. J Am Geriatr Soc (2015) 0.79
Androstenetriol improves survival in a rodent model of traumatic shock. Resuscitation (2006) 0.78
Quality assessment of tissue specimens for studies of diabetic foot ulcers. Exp Dermatol (2013) 0.78
Glucocorticoid receptor localizes to adherens junctions at the plasma membrane of keratinocytes. PLoS One (2013) 0.78
Nexus between epidermolysis bullosa and transcriptional regulation by thyroid hormone in epidermal keratinocytes. Clin Transl Sci (2008) 0.78